Msefsl

CLOSE X

Risk Disclosures on Derivatives

>9 out of 10 individual traders in equity Futures and Options Segment, incurred net losses.
>On an average, loss makers registered net trading loss close to ₹ 50,000.
>Over and above the net trading losses incurred, loss makers expended an additional 28% of net trading losses as transaction costs.
>Those making net trading profits, incurred between 15% to 50% of such profits as transaction cost.

Source:

1. SEBI study dated January 25, 2023 on “Analysis of Profit and Loss of Individual Traders dealing in equity Futures and Options (F&O) Segment”, wherein Aggregate Level findings are based on annual Profit/Loss incurred by individual traders in equity F&O during FY 2021-22.

NEPHROCARE HEALTH SERVICES LTD.

NSE : NEPHROPLUSBSE : 544647ISIN CODE : INE428V01029Industry : Hospital & Healthcare ServicesHouse : Private

BSE509.1512.75 (+2.57 %)

PREV CLOSE ( ) 496.40

OPEN PRICE ( ) 495.00

BID PRICE (QTY) 0.00 (0)

OFFER PRICE (QTY) 0.00 (0)

VOLUME 19349

TODAY'S LOW / HIGH ( )495.00 513.20

52 WK LOW / HIGH ( )445 517.5

NSE508.5512.25 (+2.47 %)

PREV CLOSE( ) 496.30

OPEN PRICE ( ) 496.30

BID PRICE (QTY) 0.00 (0)

OFFER PRICE (QTY) 508.55 (1362)

VOLUME 276094

TODAY'S LOW / HIGH( ) 496.30 514.00

52 WK LOW / HIGH ( )446 517.85

BSE NSE

1D 1M 3M 1Y 3Y 5Y

STOCK SUMMARY

Incorporation Year : 18-12 2009

Management Info

Vikram Vuppala - Chairman Vikram Vuppala - Managing Director

Registered Office

Address 5th Floor, D Block,Ilabs Centre, Plot 18, Software Units Layout,Survey No. 64, Madhapur,, Shaikpet,
Hyderabad,
Telangana-500081

Phone 040 4240 8039

Email cs@nephroplus.com

Website www.nephroplus.com

Registrars Details

K FIN Technologies Ltd.-(Karvy Fintech Pvt Ltd.)

Karvy Selenium Tower B, Plot 31-32,Gachibowli,Financial District,Nanakramguda,Hyderabad

Listing : BSE, NSE

NEWS

17Dec Nephrocare Health Services lists at 7%
Nephrocare Health Services has debuted at Rs 491.70 on the BSE, up by 31..

16Dec New Listing
Notice No. 20251216-56 Notice Date 16 Dec 2025Category Company r..

08Dec Nephrocare Health coming with IPO to r
Nephrocare HealthServicesNephrocare Health Servicesis coming out with a..

Financials

Rs. in Millions

	QTR	ANNUAL
Net Profit
Gross Profit
Operating Profit
Net Sales

ROLLING FORWARD P/E (EOD)

EVENT CALENDAR

peer group

RainbowChildrenS Med (BSE) 1185.85 (0.71%)	M.Cap ( in Cr)12043.39
Vijaya Diagnostic (BSE) 996.20 (0.60%)	M.Cap ( in Cr)9632.71
Lotus Eye Hospital (BSE) 121.95 (4.99%)	M.Cap ( in Cr)253.61
Krsnaa Diagnostics (BSE) 715.10 (0.74%)	M.Cap ( in Cr)2319.69
Apollo Hospital Ent. (BSE) 6801.30 (0.06%)	M.Cap ( in Cr)97792.26

Shareholding Pattern

	PROMOTERS	63.85%
	NON-INSTITUTION	23.88%
	MUTUAL FUNDS/UTI	3.44%
	FI/BANKS/INSURANCE	1.55%
	GOVERNMENT	0%
	FII	0%

Mf Holdings

Scheme Name	Hold(%)
No Data Found

Risk Disclosures on Derivatives

Smart Quotes

NEPHROCARE HEALTH SERVICES LTD.